Cargando…
In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
COVID-19 is a pandemic health emergency faced by the entire world. The clinical treatment of the severe acute respiratory syndrome (SARS) CoV-2 is currently based on the experimental administration of HIV antiviral drugs, such as lopinavir, ritonavir, and remdesivir (a nucleotide analogue used for E...
Autores principales: | Martorana, Annamaria, Gentile, Carla, Lauria, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472248/ https://www.ncbi.nlm.nih.gov/pubmed/32722574 http://dx.doi.org/10.3390/v12080805 |
Ejemplares similares
-
Targeting SARS-CoV-2
Main Protease for Treatment
of COVID-19: Covalent Inhibitors Structure–Activity Relationship
Insights and Evolution Perspectives
por: La Monica, Gabriele, et al.
Publicado: (2022) -
Identification of mutation resistance coldspots for targeting the SARS‐CoV2 main protease
por: Krishnamoorthy, Navaneethakrishnan, et al.
Publicado: (2021) -
How Can CpG Methylations, and Pair-to-Pair Correlations between the Main (Gene) and the Opposite Strands, Suggest a Bending DNA Loop: Insights into the 5′-UTR of DAT1
por: Di Paola, Vincenza, et al.
Publicado: (2023) -
In Silico Identification of Small Molecules as New Cdc25 Inhibitors through the Correlation between Chemosensitivity and Protein Expression Pattern
por: Lauria, Antonino, et al.
Publicado: (2021) -
In-silico analysis of caspase-3 and -7 proteases from blood-parasitic Schistosoma species (Trematoda) and their human host
por: Kumar, Shakti, et al.
Publicado: (2013)